ANTIMICROBIAL AGENT CLASSES AND SUBCLASSES
|
|
|
- Priscilla Hubbard
- 9 years ago
- Views:
Transcription
1 ANTIMICROBIAL AGENT CLASSES AND SUBCLASSES FOR USE WITH CLSI DOCUMENTS M2 AND M7 Beta-lactams: penicillins e penicillin a penicillin beta-lactam/beta-lactamase inhibitor combinations aminopenicillin a ureidopenicillin a carboxypenicillin a penicillinase-stable penicillins b amidinopenicillin amoxicillin ampicillin azlocillin mezlocillin piperacillin carbenicillin ticarcillin cloxacillin dicloxacillin methicillin nafcillin oxacillin mecillinam cephems (parenteral) cephalosporin I c,e cefazolin cephalothin cephapirin cephradine cephalosporin II c,e amoxicillin-clavulanic acid ampicillin-sulbactam aztreonam-avibactam ceftaroline-avibactam ceftazidime-avibactam ceftolozane-tazobactam piperacillin-tazobactam ticarcillin-clavulanic acid cefamandole cefonicid cefuroxime (parenteral) Antimicrobial Agent Classes and Subclasses Page 1 of 5
2 Beta-lactams (continued): Cephems (parenteral) (continued) cephalosporin III c,e cephalosporin IV c,e Cephalosporins with anti-mrsa activity cephamycin d oxacephem cefoperazone cefotaxime ceftazidime ceftizoxime ceftriaxone cefepime ceftaroline ceftobiprole cefmetazole cefotetan cefoxitin moxalactam cephems (oral) cephalosporin e cefaclor cefadroxil cefdinir cefditoren cefetamet cefixime cefpodoxime cefprozil ceftibuten cefuroxime (oral) cephalexin cephradine carbacephem loracarbef monobactams e aztreonam penems carbapenem biapenem doripenem ertapenem imipenem meropenem razupenem penem faropenem sulopenem a. Penicillinase-labile; hydrolyzed by staphylococcal penicillinase. b. Not hydrolyzed by staphylococcal penicillinase. c. Cephalosporin I, II, III, and IV are sometimes referred to as 1st-, 2nd-, 3rd-, and 4th-generation cephalosporins, respectively. Cephalosporin III and IV are also referred to as "extended-spectrum cephalosporins". This does not imply activity against ESBL-producing gram-negative bacteria. d. Athough often referred to as a 2nd-generation cephalosporin, cephamycins are not included with the other cephalosporins with regard to reporting of ESBL-producing strains. e. For all confirmed ESBL-producing strains, the test interpretation should be reported as resistant for this antimicrobial class or subclass. Abbreviations: ESBL, extended-spectrum β-lactamase; MRSA, methicillin-resistant Staphylococcus aureus. Antimicrobial Agent Classes and Subclasses Page 2 of 5
3 Non-beta-lactams: aminocyclitols aminoglycosides ansamycins folate pathway inhibitors fosfomycins spectinomycin amikacin gentamicin kanamycin netilmicin plazomicin streptomycin tobramycin rifampin iclaprim sulfonamides trimethoprim trimethoprim-sulfamethoxazole fosfomycin glycopeptides glycopeptide vancomycin lincosamides lipoglycopeptide dalbavancin oritavancin ramoplanin teicoplanin telavancin clindamycin lipopeptides macrocyclic macrolides nitrofurans nitroimidazoles oxazolidinones phenicols pseudomonic acid oxazolidinones polymyxins ketolides fluoroketolide daptomycin surotomycin colistin polymyxin B fidaxomycin azithromycin clarithromycin dirithromycin erythromycin telithromycin solithromycin nitrofurantoin metronidazole tinidazole linezolid tedizolid chloramphenicol mupirocin linezolid tedizolid Antimicrobial Agent Classes and Subclasses Page 3 of 5
4 Non-beta-lactams (continued): phenicols pseudomonic acid chloramphenicol mupirocin quinolones quinolone cinoxacin garenoxacin nalidixic acid fluoroquinolone steroidal fusidanes Fusidic acid besifloxacin ciprofloxacin clinafloxacin enoxacin finafloxacin fleroxacin gatifloxacin gemifloxacin grepafloxacin levofloxacin lomefloxacin moxifloxacin norfloxacin ofloxacin sparfloxacin trovafloxacin urifloxacin (purlifloxacin) streptogramins tetracyclines thiazolide glycyclines aminomethylcycline linopristin-flopristin quinupristin-dalfopristin doxycycline ervacycline minocycline tetracycline tigecycline omadacycline nitazoxanide tizoxanide REFERENCES Performance Standards for Antimicrobial Susceptibility Testing; Informational Supplement, M Clinical Laboratory Standards Institute (CLSI - formerly NCCLS), Wayne, PA. For more information, please consult the most current CLSI document rk Antimicrobial Agent Classes and Subclasses Page 4 of 5
5 HARDY DIAGNOSTICS 1430 West McCoy Lane, Santa Maria, CA 93455, USA Phone: (805) ext Fax: (805) Website: Distribution Centers: California Washington Utah Arizona Texas Ohio The Hardy Diagnostics manufacturing facility and quality management system is certified to ISO Copyright by Hardy Diagnostics. All rights reserved. Antimicrobial Agent Classes and Subclasses Page 5 of 5
Drug Use Review. Edward Cox, M.D. Director Office of Antimicrobial Products
Department of Health and Human Services Public Health Service Food and Drug Administration Center for Drug Evaluation and Research Drug Use Review Date: April 5, 2012 To: Through: Edward Cox, M.D. Director
Date: November 30, 2010
Department of Health and Human Services Public Health Service Food and Drug Administration Center for Drug Evaluation and Research Date: November 30, 2010 To: Through: From: Subject: Drug Name(s): Application
Liofilchem - Antibiotic Disk Interpretative Criteria and Quality Control - F14013 - Rev.7 / 20.02.2013
Liofilchem Antibiotic Disk Interpretative Criteria and Quality Control F0 Rev.7 /.02. Amikacin AK Amoxicillin + Clavulanic acid AUG (+) ATCC 352 Coagulasenegative staphylococci Amoxicillin + Clavulanic
Product Catalogue 2015 Clinical and Industrial Microbiology
Product Catalogue 201 Antibiotic discs in cartridge µg CLSI 1,2 EUCAST 3,4 BSAC Packaging * Amikacin AK x0 Discs 9004 Amoxicillin AML 2 x0 Discs 911 Amoxicillin AML x0 Discs 9133 Amoxicillin AML 2 x0 Discs
British Society for Antimicrobial Chemotherapy
British Society for Antimicrobial Chemotherapy BSAC to actively support the EUCAST Disc Diffusion Method for Antimicrobial Susceptibility Testing in preference to the current BSAC Disc Diffusion Method
Determination of minimum inhibitory concentrations. Jennifer M. Andrews* Department of Microbiology, City Hospital NHS Trust, Birmingham B18 7QH, UK
Journal of Antimicrobial Chemotherapy (2001) 48, Suppl. S1, 5 16 Determination of minimum inhibitory concentrations JAC Jennifer M. Andrews* Department of Microbiology, City Hospital NHS Trust, Birmingham
Dosing information in renal impairment
No. Drug name Usual dose Adjustment for Renal failure estimated CrCl (ml/min) Aminoglycoside antibiotics 1 Amikacin 2 Gentamicin 7.5 mg /kg q 12 hr > 50-90 7.5 mg/kg q 12 hr 10-50 7.5 mg/kg q 24 hr < 10
2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY
Measure #65 (NQF 0069): Appropriate Treatment for Children with Upper Respiratory Infection (URI) National Quality Strategy Domain: Efficiency and Cost Reduction 2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES:
Appropriate Treatment for Children with Upper Respiratory Infection
BCBS ACO Measure Appropriate Treatment for Children with Upper Respiratory Infection HEDIS Measure CPT II coding required: YES Click here to go to Table of Contents BCBS Measure: Page 50 of 234 Dated:
Received 4 July 2010; returned 10 August 2010; revised 27 September 2010; accepted 30 September 2010
J Antimicrob Chemother 2011; 66: 205 209 doi:10.1093/jac/dkq404 Advance Access publication 8 November 2010 Sustained reduction in antimicrobial use and decrease in methicillin-resistant Staphylococcus
Practice Guidelines. Updated Guideline on Diagnosis and Treatment of Intra-abdominal Infections
Updated Guideline on Diagnosis and Treatment of Intra-abdominal Infections CARRIE ARMSTRONG Guideline source: Surgical Infection Society, Infectious Diseases Society of America Literature search described?
Received 22 March 2006/Returned for modification 2 May 2006/Accepted 14 September 2006
JOURNAL OF CLINICAL MICROBIOLOGY, Nov. 2006, p. 4085 4094 Vol. 44, No. 11 0095-1137/06/$08.00 0 doi:10.1128/jcm.00614-06 Copyright 2006, American Society for Microbiology. All Rights Reserved. Two-Center
HUSRES Annual Report 2008 Martti Vaara. www.huslab.fi www.intra.hus.fi
HUSRES Annual Report 2008 Martti Vaara www.huslab.fi www.intra.hus.fi The basis of this HUSRES 2008 report is the HUSLAB/Whonet database 2008, which contains susceptibility data on about 180.000 bacteria
Antimicrobial Therapy. Otolaryngology Head and Neck Surgery
Pocket Guide to Antimicrobial Therapy in Otolaryngology Head and Neck Surgery 13th Edition DAVID N.F. FAIRBANKS, M.D. The American Academy of Otolaryngology Head and Neck Surgery Foundation EMPIRIC DRUG
for Extended Stability Parenteral Drugs Third Edition Caryn M. Bing, R.Ph., M.S., FASHP Editor
Extended Stability for Parenteral Drugs Third Edition Editor Caryn M. Bing, R.Ph., M.S., FASHP 1 American Society of Health-System Pharmacists Bethesda, Maryland Contents Preface Acknowledgments x/ Dedication
Vancomycin. Beta-lactams. Beta-lactams. Vancomycin (Glycopeptide) Rifamycins (rifampin) MID 4
Antibiotic Classes Introduction to Antimicrobials Rachel J. Gordon, MD, MPH Assistant Professor of Clinical Medicine and Epidemiology Beta-lactams Inhibit cell wall synthesis Penicillins Cephalosporins
Oscar E. Guzman, PharmD, BCPS
P Chapter 32 Antibiotic Streamlining Oscar E. Guzman, PharmD, BCPS Introduction Antibiotic streamlining is one of the most important methods pharmacists can use to encourage appropriate antibiotic use,
BD Sensi-Disc Susceptibility Test Discs
INSTRUCTIONS FOR USE BD SENSI-DISCS SD-BD.01 Rev.: May 2005 BD Sensi-Disc Susceptibility Test Discs INTENDED USE Sensi-Disc susceptibility test discs are used for semi-quantitative in vitro susceptibility
HUSRES Annual Report 2010 Martti Vaara www.huslab.fi www.intra.hus.fi
HUSRES Annual Report 2010 Martti Vaara www.huslab.fi www.intra.hus.fi Martti Vaara, 2/2011 1 The basis of this HUSRES 2010 report is the HUSLAB/Whonet database 2010, which contains susceptibility data
How To Treat Mrsa From A Dead Body
HUSRES Annual Report 2012 Martti Vaara www.huslab.fi www.intra.hus.fi Martti Vaara 2013 1 The basis of this HUSRES 2012 report is the HUSLAB/Whonet database 2012, which contains susceptibility data on
Urinary Tract Infections
Urinary Tract Infections Overview A urine culture must ALWAYS be interpreted in the context of the urinalysis and patient symptoms. If a patient has no signs of infection on urinalysis, no symptoms of
McDonald s Global Vision for Antimicrobial Stewardship in Food Animals* I
McDonald s Global Vision for Antimicrobial Stewardship in Food Animals* I Preserving antimicrobial effectiveness in the future through ethical practices today As the body of scientific evidence grows,
Version 11.1 May 2012
BSAC Methods for Antimicrobial Susceptibility Testing Version 11.1 May 2012 All enquiries to: Jenny Andrews at: + 44 (0) 121 507 5693 Email: [email protected] Contents Page Working Party members 5
How To Treat Mrsa In Finnish
HUSRES Annual Report 2013 Martti Vaara www.huslab.fi www.intra.hus.fi Martti Vaara 2014 1 The basis of this HUSRES 2013 report is the HUSLAB/Whonet database 2013, which contains susceptibility data on
The 14th EURL-AR Proficiency Test - enterococci, staphylococci and E. coli 2013. Lina Cavaco Susanne Karlsmose Rene S. Hendriksen Frank M.
The 14th EURL-AR Proficiency Test - enterococci, staphylococci and E. coli 2013 Lina Cavaco Susanne Karlsmose Rene S. Hendriksen Frank M. Aarestrup The 14TH EURL-AR Proficiency Test Enterococci, Staphylococci
Objectives. Fluids. Sterile IV Techniques. How many of you have sterile compounding technique procedures at your institution?
Objectives Intravenous Medications in the Intensive Care Unit Paul Juang, Pharm.D., BCPS Assistant Professor of Pharmacy Practice St. Louis College of Pharmacy April 16, 2011 The speaker has no conflict
Antibiotikaanvändning
Antibiotikaanvändning Akademiska sjukhuset T o m juni 2014 Receptförskriven och rekvirerad antibiotika (J01 inkl rifampicin)* Akademiska sjukhuset 2008 - juni 2014 Källa: ehälsomyndigheten 350 000 300
SEA-HLM-415 Distribution: General. Establishment of national laboratory-based surveillance of antimicrobial resistance
SEA-HLM-415 Distribution: General Establishment of national laboratory-based surveillance of antimicrobial resistance World Health Organization 2011 All rights reserved. Requests for publications, or for
Version 12 May 2013. BSAC Methods for Antimicrobial Susceptibility Testing. All enquiries to: Mandy Wootton. Email: [email protected].
BSAC Methods for Antimicrobial Susceptibility Testing Version 12 May 2013 All enquiries to: Mandy Wootton Email: [email protected] Telephone: +44 (0) 2920 746581 Contents Page Working Party members
IDSA GUIDELINES EXECUTIVE SUMMARY
IDSA GUIDELINES Diagnosis and Management of Complicated Intra-abdominal Infection in Adults and Children: Guidelines by the Surgical Infection Society and the Infectious Diseases Society of America Joseph
HUSRES Annual Report 2015
HUSRES Annual Report 2015 1 This report is based on the HUSLAB/Whonet database 2015, which contains data on more than 190.000 microbes. EUCAST 2015 clinical breakpoints have mainly been used. The doses
Antimicrobial Activity and Spectrum of PPI-0903M (T-91825), a Novel Cephalosporin, Tested against a Worldwide Collection of Clinical Strains
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Aug. 2005, p. 3501 3512 Vol. 49, No. 8 0066-4804/05/$08.00 0 doi:10.1128/aac.49.8.3501 3512.2005 Copyright 2005, American Society for Microbiology. All Rights Reserved.
Gram negatif bakterilerde GSBL üretiminin üç farklı yöntemle araştırılması ve antibiyotik direnç oranları ÖZET
Araştırma Makalesi/Original Article Makale Dili İngilizce /Article Language English Türk Hijyen ve Deneysel Biyoloji Dergisi Investigation of three different methods for detection of ESBL production and
APIC Text of Infection Control and Epidemiology. 4th Edition
APIC Text of Infection Control and Epidemiology 4th Edition TERMS OF USE By downloading the materials made available to you on the Association for Professionals in Infection Control and Epidemiology, Inc.
Beta-lactam antibiotics - Cephalosporins
Beta-lactam antibiotics - Cephalosporins Targets - PBP s Activity - Cidal - growing organisms (like the penicillins) Principles of action - Affinity for PBP s Permeability ypropertiesp Stability to bacterial
Penetration of Antimicrobial Agents into the Prostate
Pharmacology Chemotherapy 2003;49:269 279 DOI: 10.1159/000074526 Received: December 23, 2002 Accepted after revision: March 18, 2003 Penetration of Antimicrobial Agents into the Prostate Konstantin Charalabopoulos
SHEA Position Paper. Vol. 18 No. 4 INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY 275
Vol. 18 No. 4 INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY 275 SHEA Position Paper Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention
3. Metabolism generally occurs in the liver, and can lead to drug interactions, because of effects on liver enzyme systems.
arvard-mit Division of ealth Sciences and Technology ST.151: Principles of Pharmocology Instructor: Dr. Robert Rubin ST-151 1 Pharmacologic Principles of Antimicrobial Therapy I. Introduction A. Successful
bactericidal Gram+ streptococci, enterococci, meningococci, treponema pallidum (syphilis), most anaerobes poor activity against Gram- rods
Penicillin binds penicillin binding beta-lactamase proteins (transpeptidases, cleaves beta-lactam carboxypeptidases); ring and inactivates enzymes involved in cell drug wall (peptidoglycan) (chromosomal
Introduction to Antimicrobial Therapy
Introduction to Antimicrobial Therapy Christine Kubin, Pharm.D., BCPS Clinical Pharmacist, Infectious Diseases Case #1 L.G. is a 78 yo woman admitted for cardiac cath. 3-vessel disease was identified and
Helsingin ja Uudenmaan alueen herkkyystilastoja 2004. www.huslab.fi www.intra.hus.fi
Helsingin ja Uudenmaan alueen herkkyystilastoja 2004 www.huslab.fi www.intra.hus.fi Staph. aureus 2004 (%R+I) Pus and blood isolates at six hospitals (M,T,L,K,N,Ma) in Helsinki University Central Hospital,
NewYork-Presbyterian Hospital Sites: Columbia University Medical Center Guideline: Medication Use Manual Page 1 of 12
Page 1 of 12 TITLE: ANTIBIOTICS IN ADULT PATIENTS EMPIRIC USE GUIDELINES, COLUMBIA UNIVERSITY MEDICAL CENTER MEDICATION GUIDELINE PURPOSE: These are the 2011 guidelines for the empiric use of antibiotics
Urinary tract infections caused by extended spectrum β-lactamase (ESBL) producing Escherichia coli and Klebsiella pneumoniae
African Journal of Biotechnology Vol. 10(73), pp. 16661-16666, 21 November, 2011 Available online at http://www.academicjournals.org/ajb DOI: 10.5897/AJB11.2449 ISSN 1684 5315 2011 Academic Journals Full
CODE NO. PRODUCT NAME METHODOLOGY PACK SIZE HEPATITIS C
CODE NO. PRODUCT NAME METHODOLOGY PACK SIZE HEPATITIS C 53FT200-10 Signal HCV Ver. 2.0 Flow Through 10 Tests 53FT200-50 Signal HCV Ver. 2.0 Flow Through 50 Tests 53EL100-96 Innova ELISA 96 Wells HEPATITIS
Biosynthesis of Peptidoglycan 30 enzymes M G M G M G. Three stages: 1) Precursor formation: Cytoplasm M G M G M G
Online edical Tourism Agency Health Options Worldwide (HOW) Discusses India's Resistant edical Travel "Super Bug Dolly ehta 5-0236 [email protected] ND-1 (New Delhi metallo-beta-lactamase bacteria) was found
Treatment of skin and soft tissue infections due to methicillin-resistant Staphylococcus aureus in adults
1 of 6 9/24/2010 11:16 AM Official reprint from UpToDate www.uptodate.com 2010 UpToDate Treatment of skin and soft tissue infections due to methicillin-resistant Staphylococcus aureus in adults Author
The 11 th EURL-AR Proficiency Testing Salmonella and Campylobacter 2011. Susanne Karlsmose Lina M. Cavaco Rene S. Hendriksen Frank M.
The 11 th EURL-AR Proficiency Testing Salmonella and Campylobacter 2011 Susanne Karlsmose Lina M. Cavaco Rene S. Hendriksen Frank M. Aarestrup European Union Reference Laboratory - Antimicrobial Resistance
Intra-abdominal abdominal Infections
Intra-abdominal abdominal Infections Marnie Peterson, Pharm.D., BCPS Dept. of Pediatric Infectious Diseases Medical School University of Minnesota Intra-abdominal abdominal Infections Intra-abdominal abdominal
Cefuroxime apollo +9191 46 950 950
Cefuroxime apollo +9191 46 950 950 Cefuroxime apollo +9191 46 950 950 Cefuroxime CAS Number : 55268-75-2 Molecular Weight : 424.385 g/mol Molecular Formula : C16H16N4O8S Systematic (IUPAC) : (6R,7R)-3-
Outpatient Parenteral Antimicrobial Therapy
Outpatient Parenteral Antimicrobial Therapy Jason E. Bowling, MD a,b, *, James S. Lewis II, PharmD c,d, Aaron D. Owens, MD a,e KEYWORDS Outpatient parenteral antimicrobial therapy Antibiotics Adverse events
Urinary Tract Infection and Asymptomatic Bacteriuria Guidance
Urinary Tract Infection and Asymptomatic Bacteriuria Guidance Urinary tract infection (UTI) is the most common indication for antimicrobial use in hospitals and a significant proportion of this use is
Key words: antibiotics, antiseptics, resistance, burns, comlications, microorganisms.
Nazarchuk Oleksandr, Nahaichuk Vasyl, Paliy Viktor, Kovalenko Iryna. Microbiological aspects of the effectiveness of antimicrobial drugs. Journal of Education, Health and Sport. 2015;5(6):19-28. ISSN 2391-8306.
ANNUAL REPORT ON STAPHYLOCOCCUS AUREUS BACTERAEMIA CASES IN DENMARK 2008 (part I)
ANNUAL REPORT ON STAPHYLOCOCCUS AUREUS BACTERAEMIA CASES IN DENMARK 2008 (part I) STAPHYLOCOCCUS LABORATORY, STATENS SERUM INSTITUT 1 Staphylococcus aureus bacteraemia annual report, part I The format
ANNUAL REPORT ON STAPHYLOCOCCUS AUREUS BACTERAEMIA CASES IN DENMARK 2009 (part I)
ANNUAL REPORT ON STAPHYLOCOCCUS AUREUS BACTERAEMIA CASES IN DENMARK 2009 (part I) STAPHYLOCOCCUS LABORATORY, STATENS SERUM INSTITUT 1 Staphylococcus aureus Bacteraemia Annual Report, Part I The annual
CAP, HAP, VAP, & HCAP
Objectives Following the presentation, the participant will be able to: CP, HP, VP, & HCP John C. Rotschafer, Pharm. D. Professor College of Pharmacy University of Minnesota 1. Identify typical, atypical,
National surveillance and reporting of. and antibiotic usage for human health in Australia. June 2013. Antimicrobial Resistance Standing Committee
National and reporting of antimicrobial resistance and antibiotic usage for human health in Australia June 2013 Antimicrobial Resistance Standing Committee Commonwealth of Australia 2013 ISBN 987 1-921983
OIE LIST OF ANTIMICROBIAL AGENTS OF VETERINARY IMPORTANCE
Criteria used for categorisation List of antimicrobial agents OIE LIST OF OF VETERINARY IMPORTANCE The OIE 1 International Committee unanimously adopted the List of Antimicrobial Agents of Veterinary Importance
A role for Propionibacterium acnes in post-operative orthopedic implant infections Katherine P. Lemon, MD PhD Joint ID Conference April 28, 2003
A role for Propionibacterium acnes in post-operative orthopedic implant infections Katherine P. Lemon, MD PhD Joint ID Conference April 28, 2003 In the US annually there are 600,000 joint prostheses and
TRANSPARENCY COMMITTEE
The legally binding text is the original French version TRANSPARENCY COMMITTEE Opinion 28 May 2014 MABELIO 500 mg, powder for concentrate for solution for infusion B/10 vials (CIP: 34009 277 316 6 2) Applicant:
FORMULARY. (List of Covered Drugs) Molina Dual Options Medicare-Medicaid Plan
FORMULARY (List of Covered Drugs) 2015 Molina Dual Options Medicare-Medicaid Plan Version 14 UPDATED: 11/2015 Member Services (877) 901-8181, TTY/TDD 711 Monday - Friday, 8 a.m. - 8 p.m. local time H8046_15_16003_0002_MMPILRx
The State of Therapeutics in Eye Care (Part I)
The State of Therapeutics in Eye Care (Part I) Ron Melton, OD, FAAO Randall Thomas, OD, MPH, FAAO www.eyeupdate.com 1 st World Congress of Optometry Medellin, Columbia August 14-16, 2015 Gilenya First
ORIGINAL ARTICLE. 10.1111/j.1469-0691.2006.01613.x
ORIGINAL ARTICLE 10.1111/j.1469-0691.2006.01613.x Benchmarking antimicrobial drug use at university hospitals in five European countries V. Vlahović-Palc evski 1, U. Dumpis 2, P. Mitt 3, J. Gulbinovic
How To Get A Drug Plan To Pay For A Prescription From Acpa
+B/LVW2I'UXJV5B$SSURYHG 2015 List of Covered s (Formulary) FOR MORE INFORMATION, contact Member Services at 1-855-735-4398 from 8 a.m. to 8 p.m., seven days a week. TTY users call 711. On weekends and
GLOBAL OVERVIEW OF ANTIMICROBIAL RESISTANCE STD AGENTS
GLOBAL OVERVIEW OF ANTIMICROBIAL RESISTANCE STD AGENTS IN Dr.P.Bhalla Director Professor and Head Dept. of Microbiology Maulana Azad Medical College New Delhi, INDIA STDs & RTIs l HIV l Gonococcal infections/
MARAN 2015. NethMap 2015. Consumption of antimicrobial agents and antimicrobial resistance among medically important bacteria in the Netherlands
NethMap 215 Consumption of antimicrobial agents and antimicrobial resistance among medically important bacteria in the Netherlands MARAN 215 Monitoring of Antimicrobial Resistance and Antibiotic Usage
Treatment of Fever and Infection in Children with Transfusion Dependent Thalassaemia
Treatment of Fever and Infection in Children with Transfusion Dependent Thalassaemia Document Information Version: 2 Date: June 2014 Authors (incl. job title): Professor David Rees, Sue Height (consultant
Antibiotics and Infectious Disease in Otolaryngology-HNS
Antibiotics and Infectious Disease in Otolaryngology-HNS Glen T. Porter, MD Faculty Advisor: Francis B. Quinn, MD, FACS The University of Texas Medical Branch at Galveston Department of Otolaryngology
Streptococcus pneumoniae IgG AB (13 Serotypes), MAID... 7
Volume 12 December 2011 Table of Contents Summary of Test Changes... 3 Test Changes... 6 Human Anti-Mouse AB (HAMA), ELISA... 6 Hepatitis E Antibody (IgG, IgM)... 6 Hepatitis E Antibody (IgG)... 6 Hepatitis
Open Access Article pissn 0976 3325 eissn 2229 6816
Original Article A STUDY OF EXTENDED SPECTRUM β-lactamase (ESBL) AND AmpC β-lactamase PRODUCING KLEBSIELLA PNEUMONIAE IN NEONATAL INTENSIVE CARE UNIT AT TERTIARY CARE HOSPITAL, AHMEDABAD Modi Dhara J 1,
AETNA BETTER HEALTH OF OHIO a MyCare Ohio plan
AETNA BETTER HEALTH OF OHIO a MyCare Ohio plan 2015 List of Covered Drugs/Formulary Aetna Better Health of Ohio, a MyCare Ohio plan (Medicare-Medicaid Plan) is a health plan that contracts with Medicare
Appendix M: Guidelines for the Prophylaxis and Management of Intraabdominal, Biliary, and Appendiceal Infections
Appendix M: Guidelines for the Prophylaxis and Management of Intraabdominal, Biliary, and Appendiceal Infections University of Wisconsin Hospital and Clinics Intraabdominal Infections Prophylaxis and Management
NEW SCHEDULE H1 INSERTED IN DRUGS AND COSMETICS RULES :
LOCOST 85, GIDC Estate, Por-Ramangamdi, N.H.8, Dist. Vadodara - 391 243 Gujarat, India. Tel. No.: (91-265) 2830009 Fax No.: (P.P.) 2831446 E-mail: [email protected] Website: www.locostindia.com A Public
Prevalence of Klebsiella pneumoniae Encoding Genes for Ctx-M-1, Tem-1 and Shv-1 Extended-Spectrum Beta Lactamases (ESBL) Enzymes in Clinical Specimens
Jundishapur J Microbiol. 2013 December; 6(10): e8256. Published online 2013 December 1. DOI: 10.5812/jjm.8256 Research Article Prevalence of Klebsiella pneumoniae Encoding Genes for Ctx-M-1, Tem-1 and
Rational Selection of Antimicrobials for Use in Horses
Rational Selection of Antimicrobials for Use in Horses W. David Wilson, BVMS, MRCVS, MS Author s address: Department of Medicine and Epidemiology (VM:VME), School of Veterinary Medicine, University of
ANTIMICROBIAL USE GUIDELINES
ANTIMICROBIAL USE GUIDELINES University of Wisconsin Hospital and Clinics Pharmacy and Therapeutics Committee Department of Pharmacy Drug Policy Program July 2011 to June 2012 Twenty-First Edition PREFACE
How To Test For Carbapenemase
Available online at www.scholarsresearchlibrary.com Annals of Biological Research, 2012, 3 (12):5659-5664 (http://scholarsresearchlibrary.com/archive.html) ISSN 0976-1233 CODEN (USA): ABRNBW A study on
ANTIBIOTIC RESISTANCE THREATS. in the United States, 2013
ANTIBIOTIC RESISTANCE THREATS in the United States, 2013 TABLE OF CONTENTS Foreword... 5 Executive Summary.... 6 Section 1: The Threat of Antibiotic Resistance... 11 Introduction.... 11 National Summary
Health PEI: Provincial Antibiotic Advisory Team Skin & Soft Tissue Infection Empiric Treatment Guidelines Prevention
Syndrome Cellulitis / Erysipelas/ Necrotizing Fasciitis If Fournier s gangrene (pelvic / genital area gangrene) suspected: same treatment as severe sepsis. PLEASE NOTE: Redness and edema increase for 1-2
Antibacterial. Agents. Structure Activity Relationships. André Bryskier MD
Antibacterial Agents Structure Activity Relationships André Bryskier MD 1 Lille - December 7 th 2004 Antibacterial Agents atural compounds Synthetic compounds Beta-lactams Aminoglycosides Macrolides Streptogramin
2015 Formulary (List of Covered Drugs)
Blue Cross Medicare Advantage Basic (HMO) SM Blue Cross Medicare Advantage Premier Plus (HMO-POS) SM 015 Formulary (List of Covered Drugs) PLEASE READ: THIS DOCUMENT CONTAINS INFORMATION ABOUT THE DRUGS
Bacterial Infections Caused by Achromobacter xylosoxidans
Bacterial Infections Caused by Achromobacter xylosoxidans Mohammed Kadum Al-Araji Samah Ali College of Pharmacy, Al-Mustanseriyia University, Baghdad, Iraq. Corresponding author: E-mail: [email protected]
Prescription Drug Guide
2012 Prescription Drug Guide Humana Group Medicare Formulary List of covered drugs Humana Group Medicare Plus 3 PLEASE READ: THIS DOCUMENT CONTAINS INFORMATION ABOUT THE DRUGS WE COVER IN THIS PLAN. Y0040_PDG12b_Final_522C
ANTIBIOTICS IN SEPSIS
ANTIBIOTICS IN SEPSIS Jennifer Curello, PharmD, BCPS Clinical Pharmacist, Infectious Diseases Antimicrobial Stewardship Program Ronald Reagan UCLA Medical Center October 27, 2014 The power of antibiotics
Venkatadri Babu. et al. / International Journal of Biological & Pharmaceutical Research. 2014; 5(1): 66-70.
66 e- ISSN 0976-3651 Print ISSN 2229-7480 International Journal of Biological & Pharmaceutical Research Journal homepage: www.ijbpr.com IJBPR MULTIDRUG RESISTANT ESCHERICHIA COLI AND KLEBSIELLA PNEUMONIAE
IDSA GUIDELINES EXECUTIVE SUMMARY
IDSA GUIDELINES International Clinical Practice Guidelines for the Treatment of Acute Uncomplicated Cystitis and Pyelonephritis in Women: A 2010 Update by the Infectious Diseases Society of America and
Protein Synthesis Inhibitors
Frank Lowy Protein Synthesis Inhibitors This lecture discusses a diverse group of antibiotics that are grouped together because they all have a common mechanism of action they are protein synthesis inhibitors.
Antimicrobial Stewardship at the Bedside of Patient Care: Clinical Cases
Antimicrobial Stewardship at the Bedside of Patient Care: Clinical Cases Debra Goff, PharmD, FCCP The Ohio State University Wexner Medical Center, Columbus, OH David P. Nicolau, PharmD, FCCP, FIDSA Hartford
